share_log

Avantor Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

Avantor Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

avantor參與2024年生物過程國際會議科學項目和展覽
PR Newswire ·  09/23 20:05

RADNOR, Pa., Sept. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the Company will deliver multiple scientific presentations and exhibit at BioProcess International 2024, scheduled for September 23-26 in Boston. Over 3,200 biopharmaceutical development and production professionals representing 40-plus countries are expected to attend.

賓夕法尼亞州雷德諾,2024年9月23日/美通社/--全球領先的生命科學和先進科技行業關鍵任務產品和服務提供商Avantor,Inc.(紐約證券交易所: AVTR)宣佈公司將在波士頓舉辦的BioProcess International 2024上發表多個科學演講並展示。預計將有來自40多個國家的3200多名生物製藥開發和生產專業人士參加此次會議,會議定於9月23日至26日舉行。

Avantor's scientific presentations at BioProcess International 2024 include:

Avantor在BioProcess International 2024年的科學演講包括:

Presenter - Jungmin Oh, Ph.D., Senior Manager, New Product Development
Session Title - A novel approach to optimization of AAV harvest and purification process
Date and Time - September 25, 12:30 pm

演講者-博士Jungmin Oh,新產品開發高級經理
會議主題-一種優化AAV收穫和純化過程的新方法
日期和時間-9月25日,下午12:30

Presenter - Nandu Deorkar, Ph.D., Senior Vice President, Biopharma Production Research & Development
Session Title - Keynote Address: Adapting to Changing Molecules and Regulatory Expectations
Date and Time – September 26, 10:00 am

演講者-博士Nandu Deorkar,生物製藥生產研發高級副總裁
會議主題-主題演講:適應變化中的分子和監管期望
日期和時間-9月26日,上午10:00

Presenter - Jerry Keybl, Ph.D., Senior Vice President, Biopharma Products & Strategy
Session Title - Viral Gene Therapy Manufacturing at Scale – Assembling Solutions to Drive Industrialization
Date and Time - September 26, 12:15 pm

演講者-傑瑞·凱布爾博士,生物製藥產品與戰略高級副總裁
會議主題-規模下的病毒基因療法制造-組裝解決方案推動產業化
日期和時間-9月26日,下午12:15

"Avantor's significant presence at BioProcess International 2024 is a testament to our reputation for delivering leading solutions across the spectrum of biopharmaceutical development and production," said Benoit Gourdier, Executive Vice President and Head of Avantor's Bioscience Production Segment. "We look forward to engaging with customers and attendees in Boston and showcasing how our innovative solutions can help solve their most demanding production challenges."

「Avantor在BioProcess International 2024展現的重要存在證明了我們在生物製藥發展和生產領域提供領先解決方案的聲譽,」該公司生命科學生產部門執行副總裁兼頭崗負責人貝努瓦·固爾迪耶表示。「我們期待與波士頓的客戶和與會者互動,展示我們的創新解決方案如何幫助解決其最嚴峻的生產挑戰。」

In addition to its multiple scientific presentations, Avantor will also have a strong presence on the exhibit floor, focusing on its industry leading solutions for production scale up and downstream process optimization. Avantor will present its Magnetic Mixing Systems portfolio, which ranges from 50 to 1500 liters, and now includes a newly launched tabletop mixer for single-use mixing needs. These scalable Magnetic Mixing Systems are designed to maximize mixing efficiency with low shear rates, ensuring consistent homogeneity and minimizing risk to product quality. Avantor's experienced team of engineers can also help design specialized solutions tailored to customers unique bioprocessing mixing needs.

除了多個科學演示外,Avantor還將在展位上展示強大存在,重點放在其行業領先的生產規模擴大和下游工藝優化解決方案上。Avantor將展示其磁性攪拌系統產品組合,涵蓋從50到1500升的範圍,現在還包括新推出的用於一次性混合需求的桌面混合器。這些可擴展的磁性攪拌系統旨在通過低剪切速率來最大化混合效率,確保一致均勻性,並將產品質量風險降至最低。Avantor經驗豐富的工程團隊還可以幫助設計專門針對客戶獨特生物加工混合需求的解決方案。

About Avantor
Avantor is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.

關於 avantor,它是一家領先的生命科學工具公司,向生命科學和先進科技行業的客戶提供關鍵產品和服務。我們在整個科研過程中與客戶並肩工作,促進醫學、醫療保健和技術的突破。我們的產品組合在幾乎每個最重要的研究、開發和生產活動的各個階段都被應用,在180個國家的300,000多個客戶位置使用。有關更多信息,請訪問 avantorsciences.com 並在 LinkedIn,X(Twitter)和 Facebook 上找到我們。
Avantor是一家領先的生命科學工具公司,也是向生命科學和高級技術行業提供使命關鍵產品和服務的全球供應商。我們與客戶並肩合作,共同推動科學進步,以促成醫學、健康保健和技術領域的突破。我們的產品組合幾乎在重要研究、開發和生產活動的每個階段均被使用,在全球180個國家的30多萬客戶場所進行重要的研究,開發和生產活動。欲了解更多信息,請訪問 avantorsciences.com,並在LinkedIn上找到我們,在Twitter和Facebook上跟蹤我們。

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
[email protected]

全球媒體聯繫人
Eric Van Zanten
外部通信負責人Lina Danstrup;電話:+45 30 77 05 52;anse@novozymes.com。
Avantor
610-529-6219
[email protected]

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
[email protected]

投資者關係聯繫人
Christina Jones
投資者關係副總裁
Avantor
805-617-5297
[email protected]

SOURCE Avantor and Financial News

資料來源:Avantor和Financial News

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?

440k+
440k+

Newsrooms &
新聞發佈室&

Influencers
影響力
9k+
9k+

Digital Media
數字媒體

Outlets
賣場
270k+
270k+

Journalists
新聞記者

Opted In
已選擇加入
GET STARTED
開始使用

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論